Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease

dc.contributor.author
Juárez Flores, Diana Luz
dc.contributor.author
González Casacuberta, Ingrid
dc.contributor.author
Ezquerra Trabalón, Mario
dc.contributor.author
Bañó, Maria
dc.contributor.author
Carmona Pontaque, Francesc
dc.contributor.author
Catalán García, Marc
dc.contributor.author
Guitart Mampel, Mariona
dc.contributor.author
Rivero, Juan José
dc.contributor.author
Tobías, Ester
dc.contributor.author
Milisenda, José
dc.contributor.author
Tolosa, Eduardo
dc.contributor.author
Martí Domènech, Ma. Josep
dc.contributor.author
Fernández Santiago, Rubén
dc.contributor.author
Cardellach, Francesc
dc.contributor.author
Morén Núñez, Constanza
dc.contributor.author
Garrabou Tornos, Glòria
dc.date.issued
2019-05-09T11:43:03Z
dc.date.issued
2019-05-09T11:43:03Z
dc.date.issued
2018-06-08
dc.date.issued
2019-05-09T11:43:03Z
dc.identifier
1479-5876
dc.identifier
https://hdl.handle.net/2445/132882
dc.identifier
681148
dc.description.abstract
BACKGROUND: Mutations in leucine rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease (PD). Mitochondrial and autophagic dysfunction has been described as etiologic factors in different experimental models of PD. We aimed to study the role of mitochondria and autophagy in LRRK2 G2019S -mutation, and its relationship with the presence of PD-symptoms. METHODS: Fibroblasts from six non-manifesting LRRK2 G2019S -carriers (NM-LRRK2 G2019S ) and seven patients with LRRK2 G2019S -associated PD (PD-LRRK2 G2019S ) were compared to eight healthy controls (C). An exhaustive assessment of mitochondrial performance and autophagy was performed after 24-h exposure to standard (glucose) or mitochondrial-challenging environment (galactose), where mitochondrial and autophagy impairment may be heightened. RESULTS: A similar mitochondrial phenotype of NM-LRRK2 G2019S and controls, except for an early mitochondrial depolarization (54.14% increased, p = 0.04), was shown in glucose. In response to galactose, mitochondrial dynamics of NM-LRRK2 G2019S improved (- 17.54% circularity, p = 0.002 and + 42.53% form factor, p = 0.051), probably to maintain ATP levels over controls. A compromised bioenergetic function was suggested in PD-LRRK2 G2019S when compared to controls in glucose media. An inefficient response to galactose and worsened mitochondrial dynamics (- 37.7% mitochondrial elongation, p = 0.053) was shown, leading to increased oxidative stress. Autophagy initiation (SQTSM/P62) was upregulated in NM-LRRK2 G2019S when compared to controls (glucose + 118.4%, p = 0.014; galactose + 114.44%, p = 0.009,) and autophagosome formation increased in glucose media. Despite of elevated SQSTM1/P62 levels of PD-NM G2019S when compared to controls (glucose + 226.14%, p = 0.04; galactose + 78.5%, p = 0.02), autophagosome formation was deficient in PD-LRRK2 G2019S when compared to NM-LRRK2 G2019S (- 71.26%, p = 0.022). CONCLUSIONS: Enhanced mitochondrial performance of NM-LRRK2 G2019S in mitochondrial-challenging conditions and upregulation of autophagy suggests that an exhaustion of mitochondrial bioenergetic and autophagic reserve, may contribute to the development of PD in LRRK2 G2019S mutation carriers.
dc.format
14 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s12967-018-1526-3
dc.relation
Journal of Translational Medicine, 2018, vol. 16, num. 1, p. 160-173
dc.relation
https://doi.org/10.1186/s12967-018-1526-3
dc.rights
cc-by (c) Juárez Flores, Diana Luz et al., 2018
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject
Malaltia de Parkinson
dc.subject
Autofàgia
dc.subject
Fibroblasts
dc.subject
Mitocondris
dc.subject
Parkinson's disease
dc.subject
Autophagy
dc.subject
Fibroblasts
dc.subject
Mitochondria
dc.title
Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.